HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased acetylation of H3K14 in the genomic regions that encode trained immunity enzymes in lysophosphatidylcholine-activated human aortic endothelial cells - Novel qualification markers for chronic disease risk factors and conditional DAMPs.

Abstract
To test our hypothesis that proatherogenic lysophosphatidylcholine (LPC) upregulates trained immunity pathways (TIPs) in human aortic endothelial cells (HAECs), we conducted an intensive analyses on our RNA-Seq data and histone 3 lysine 14 acetylation (H3K14ac)-CHIP-Seq data, both performed on HAEC treated with LPC. Our analysis revealed that: 1) LPC induces upregulation of three TIPs including glycolysis enzymes (GE), mevalonate enzymes (ME), and acetyl-CoA generating enzymes (ACE); 2) LPC induces upregulation of 29% of 31 histone acetyltransferases, three of which acetylate H3K14; 3) LPC induces H3K14 acetylation (H3K14ac) in the genomic DNA that encodes LPC-induced TIP genes (79%) in comparison to that of in LPC-induced effector genes (43%) including ICAM-1; 4) TIP pathways are significantly different from that of EC activation effectors including adhesion molecule ICAM-1; 5) reactive oxygen species generating enzyme NOX2 deficiency decreases, but antioxidant transcription factor Nrf2 deficiency increases, the expressions of a few TIP genes and EC activation effector genes; and 6) LPC induced TIP genes(81%) favor inter-chromosomal long-range interactions (CLRI, trans-chromatin interaction) while LPC induced effector genes (65%) favor intra-chromosomal CLRIs (cis-chromatin interaction). Our findings demonstrated that proatherogenic lipids upregulate TIPs in HAECs, which are a new category of qualification markers for chronic disease risk factors and conditional DAMPs and potential mechanisms for acute inflammation transition to chronic ones. These novel insights may lead to identifications of new cardiovascular risk factors in upregulating TIPs in cardiovascular cells and novel therapeutic targets for the treatment of metabolic cardiovascular diseases, inflammation, and cancers. (total words: 245).
AuthorsYifan Lu, Yu Sun, Charles Drummer 4th, Gayani K Nanayakkara, Ying Shao, Fatma Saaoud, Candice Johnson, Ruijing Zhang, Daohai Yu, Xinyuan Li, William Y Yang, Jun Yu, Xiaohua Jiang, Eric T Choi, Hong Wang, Xiaofeng Yang
JournalRedox biology (Redox Biol) Vol. 24 Pg. 101221 (06 2019) ISSN: 2213-2317 [Electronic] Netherlands
PMID31153039 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
Chemical References
  • Biomarkers
  • Histones
  • Lysophosphatidylcholines
Topics
  • Acetylation
  • Adaptive Immunity
  • Aorta (metabolism)
  • Atherosclerosis (etiology, metabolism, pathology)
  • Biomarkers
  • Chronic Disease
  • Disease Susceptibility
  • Endothelial Cells (metabolism)
  • Gene Expression Regulation
  • Genes, Essential
  • Histones (metabolism)
  • Humans
  • Lysophosphatidylcholines (metabolism)
  • Metabolic Networks and Pathways
  • Models, Biological
  • Risk Factors
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: